Patents by Inventor JONAS ODMAN

JONAS ODMAN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical Compositions
    Publication number: 20080058399
    Abstract: The present invention provides pharmaceutical compositions comprising as an active ingredient candesartan or candesartan cilexetil, compositions exhibiting a relative bioavailability, measured as area under the curve, of more than 1.5.
    Type: Application
    Filed: September 5, 2007
    Publication date: March 6, 2008
    Applicant: ASTRAZENECA AB
    Inventors: Bertil Abrahamsson, Jonas Odman
  • PHARMACEUTICAL COMPOSITION FOR SUSTAINED RELEASE OF THE HMG-COA REDUCTASE INHIBITOR FLUVASTATIN
    Publication number: 20030194440
    Abstract: The present invention relates to pharmaceutical compositions for sustained release comprising a water soluble salt of the HMG-CoA reductase inhibitor fluvastatin as active ingredient, said composition being selected from the group comprising matrix formulations, diffusion-controlled membrane coated formulations; and combinations thereof.
    Type: Application
    Filed: October 24, 1997
    Publication date: October 16, 2003
    Inventors: JAN-ERIK LOFROTH, JONAS ODMAN